Litigation

New Jersey Court Considers Expanding Litigation Against Monsanto Over Roundup Claims

by

TRENTON, N.J. — The New Jersey Supreme Court has received a new filing seeking to categorize a batch of lawsuits against Monsanto Co. and Bayer AG as multicounty litigation, a move that underscores ongoing legal scrutiny over claims of harm linked to the weed killer Roundup. This marks the second such attempt to consolidate these injury claims, signaling a continued effort to address the allegations collectively. The increasing litigation stems from accusations that exposure to Roundup has caused severe health issues. The lawsuits assert that Monsanto, now owned by Bayer AG, failed to warn users … Read more

Litigation Expert Justin VandenBout Joins Norton Rose Fulbright in Houston, Bolsters Firm’s Nationwide Practice

by

Houston, TX – Norton Rose Fulbright, a prominent global law firm, announced the addition of Justin VandenBout to its Houston office, where he will serve as a partner in the firm’s specialized Products, Pharma, Medical and Mass Tort practice team. VandenBout, formerly of Chamberlain Hrdlicka, brings extensive experience in commercial, product liability, insurance coverage, and mass tort litigation across numerous state and federal jurisdictions in the United States. VandenBout’s portfolio includes handling complex litigation for both plaintiffs and defendants, with a resume highlighting his involvement in high-stakes cases from Texas to California and several states … Read more

Nassau County Supreme Court Implements New Filing Procedures for Orders to Show Cause, Enhancing Litigation Process

by

MINEOLA, N.Y. — In a significant update to the procedural practices of the Nassau County Supreme Court, attorneys and litigants are now required to navigate new regulations regarding the filing of orders to show cause. These orders, commonly applied in urgent legal matters seeking immediate relief such as stays or temporary restraining orders, have evolved with recent amendments, aiming to streamline judicial processes and promote timely communications. At the heart of these amendments is a modification to the pre-existing rule under 22 NYCRR § 202.7(f). This rule mandates that the opposing party receives prior notification … Read more

Andrew Kaplan to Illuminate Key Developments in Drug and Medical Device Litigation at Upcoming Industry Panel

by

Legal expert Andrew Kaplan is slated to address key developments in drug and medical device litigation at an upcoming panel discussion titled “Drug and Medical Device Litigation Year in Review.” Kaplan, a seasoned attorney within this specialized field, will examine pivotal changes and delve into their implications for future legal practices and proceedings. The panel, set to convene soon, aims to dissect significant court rulings from the past year that have shaped the landscape of litigation concerning pharmaceuticals and medical devices. These decisions, often setting precedence, have played a crucial role in shaping the legal … Read more